Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Six clinical trial patients admitted to critical care

Home > PJ (current issue) > News / NewsCentre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7392 p307
18 March 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Six clinical trial patients admitted to critical care

Six patients involved in a Phase 1 clinical trial of a drug being developed for leukaemia, rheumatoid arthritis and mutliple sclerosis were admitted to critical care this week.

The Medicines and Healthcare products Regulatory Agency has suspended the trial, and says it has been assured that no one else has been given the product.

Eight healthy male volunteers aged 18–40 years were involved in the trial of TGN 1412, being developed by TeGenero AG, six of whom took the drug. The two patients who were given a placebo were unaffected. The patients were admitted to critical care at Northwick Park Hospital, London, from an independent medical research unit operated at the hospital by Parexel, a US company which provides clinical trial services. As The Journal went to press, the patients were in a serious condition and being monitored closely.

The MHRA will be sending inspectors to the unit to start investigations and will be working with North West London Strategic Health Authority, the Department of Health and the Metropolitan Police.

MHRA chief executive officer Kent Woods said: “Our immediate priority has been to ensure than no further patients are harmed. We will now undertake an exhaustive investigation to determine the cause and ensure all appropriate actions are taken.”

Back to Top

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20016875

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.